ALDACTONE; ALDACTONE-A; PRACTON

Pfizer Inc

Revision date : 2012-04-03

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

232-679-6/9005-25-8

Name of the chemical

Starch

Concentration

*

EC/CAS

25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

*

EC/CAS

9003-39-8

Name of the chemical

polyvinylpyrrolidone

Concentration

*

EC/CAS

8006-90-4

Name of the chemical

Mentha piperita oil (40)

Concentration

*

EC/CAS

9004-65-3

Name of the chemical

methylhydroxypropylcellulose

Concentration

*

EC/CAS

200-133-6

Name of the chemical

Spironolactone (INN)

Concentration

10-20%

EC/CAS

209-150-3

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

*

General Information

Version

1.3

Revision date

2012-04-03

Product name

ALDACTONE; ALDACTONE-A; PRACTON

Chemical name

Mixture

1.2.1 Relevant identified uses

Pharmaceutical product for the treatment of high blood pressure (hypertension)

Emergency telephone

1-800-424-9300, +1-703-527-3887

Icons in SDS

Company Information

company name

Pfizer Inc

e-mail address of the competent person responsible for the Safety Data Sheet

pfizer-MSDS@pfizer.com

GHS Information

Signal word

WARNING

Hazard Codes

Hazard statements (CLP)

H351, H371

Hazard statements

Code

Statements

H351

Suspected of causing cancer

Section 2

SECTION 2: Hazards identification

Appearance Yellow, Orange, Peach Tablet

Signal word

WARNING

Hazard statements

Suspected of causing cancer. May cause damage to: blood and blood-forming organs through prolonged or repeated exposure.

Additional information

Short Term May be absorbed through the skin and cause systemic effects. Antihypertensive drug: has blood pressure-lowering properties Known Clinical Effects Adverse effects seen in clinical use include gastrointestinal discomfort, dizziness, and headache. Hypersensitivity reactions may also occur in susceptible individuals. Effects on blood and blood-forming organs have also occurred. EU Indication of danger Toxic to Reproduction: Category 2 Carcinogenic: Category 3 Harmful EU Hazard Symbols EU Risk Phrases R40 - Limited evidence of a carcinogenic effect R48/22 - Harmful: danger of serious damage to health by prolonged exposure if swallowed. R60 - May impair fertility. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.